FGF21 and metabolic dysfunction-associated steatotic liver disease: As seen in Figure 1, both subjects with and without CAD showed a significant elevation of serum FGF21 level in the NAFLD group compared to the non-NAFLD group (415.5 pg/mL (258.0-693.7) vs.